HiActi® Recombinant Human VEGF-D Protein 重组人血管内皮生长因子-D

Scan for product

CHO细胞表达系统血管生成研究淋巴管生成研究肿瘤研究

Product no.91525ES Sizes2 options SourceYeasen · Official

Cat. No. 91525ES10

现货 $1,445.00

Qty 1

Enquire now

Enquire / bulk Compare

Specifications & Enquiry

Tick the specs you need to submit them together; or enquire one by one. Cat. numbers are carried into the RFQ.

Cat.No Spec Price Status

91525ES10 10 μg $1,445.00 现货 Enquire

91525ES50 50 μg $4,525.00 现货 Enquire

Submit enquiry Price is on application; bulk sizes can be sampled on request.

Overview

Specifications

Brand翌圣生物 Yeasen

Cat.No91525ES

Purity> 95% as analyzed by SDS-PAGE,> 95% as analyzed by HPLC

Specification10 μg

Origin翌圣生物科技(上海)股份有限公司

技术平台 CHO细胞表达系统

应用方法 血管生成研究研究VEGF-D在血管生成中的作用 淋巴管生成研究研究VEGF-D在淋巴管生成中的作用 肿瘤研究研究肿瘤淋巴道重建和淋巴结转移

适用物种种属人

检测方法 SDS-PAGE HPLC 凝胶凝结法 细胞增殖实验

生物特性参数 蛋白类型重组蛋白 种属来源人 生物活性描述与VEGFR-2和VEGFR-3受体结合，激活下游信号，促进血管生成、淋巴管生成和内皮细胞生长 应用血管生成、淋巴管生成、肿瘤研究 组织表达在肺、心脏和小肠中高度表达，在骨骼肌、结肠和胰腺中表达水平较低 受体VEGFR-2 VEGFR-3

技术参数纯度> 95% as analyzed by SDS-PAGE > 95% as analyzed by HPLC 内毒素水平< 1.0 EU/μg of protein by gel clotting method 分子量18-19 kDa on SDS-PAGE under reducing conditions. 制剂形式Lyophilized after extensive dialysis against PBS. 活性ED50 < 1.0 μg/ml measured in a cell proliferation assay using HUVEC cells. 表达系统CHO 标签No Tag 表达序列Phe89-Arg205 UniProt编号O43915 外观Lyophilized Powder 复溶方法It is recommended that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute the lyophilized powder in ddH₂O or PBS up to 100 μg/ml. 储存条件-85 ~ -65℃保存，收到货之后有效期6个月。复溶后，产品在4°C下稳定2周，在-20°C下稳定3个月。避免反复冻融循环。